Building The Case For Biotechnology
DOWNLOAD
Download Building The Case For Biotechnology PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Building The Case For Biotechnology book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page
Building The Case For Biotechnology
DOWNLOAD
Author : Mark J. Ahn
language : en
Publisher:
Release Date : 2010
Building The Case For Biotechnology written by Mark J. Ahn and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010 with Business & Economics categories.
This volume helps to fill the void in life science entrepreneurship and management case books and provides faculty and students with not only the charts, but the simulated experience of sailing the turbulent and exciting oceans of the biomedical industry toward creating significant value for patients and society.
Building Biotechnology
DOWNLOAD
Author : Yali Friedman
language : en
Publisher:
Release Date : 2014
Building Biotechnology written by Yali Friedman and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014 with Biotechnology industries categories.
Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, policy, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs. This fourth edition significantly expands upon the foundation laid by the first three, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables. Most importantly, Building Biotechnology enables seasoned business professionals and entrepreneurial scientists alike to understand the drivers of biotechnology businesses and apply their established skills for commercial success.
Building Biotechnology
DOWNLOAD
Author : Yali Friedman
language : en
Publisher: Logos Press
Release Date : 2014-01-01
Building Biotechnology written by Yali Friedman and has been published by Logos Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-01-01 with Business & Economics categories.
Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, policy, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs. This fourth edition significantly expands upon the foundation laid by the first three, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables. Most importantly, Building Biotechnology enables seasoned business professionals and entrepreneurial scientists alike to understand the drivers of biotechnology businesses and apply their established skills for commercial success.
Building Biotechnology
DOWNLOAD
Author : Yali Friedman
language : en
Publisher: Thinkbiotech
Release Date : 2004
Building Biotechnology written by Yali Friedman and has been published by Thinkbiotech this book supported file pdf, txt, epub, kindle and other format this book has been release on 2004 with Business & Economics categories.
Building Biotechnology helps readers understand the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs including MBA programs at UC Irvine, Tepper, and Boston University; the Johns Hopkins biotechnology MS/MBA program; NIH Office of Technology Transfer; extension programs at Berkeley and UCSF; and international programs at the Karolinska Institute, Macquarie University, and Schulich School of Business. This fourth edition significantly expands upon the foundation laid by the first three, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables. Most importantly, Building Biotechnology enables seasoned business professionals and entrepreneurial scientists alike to understand the drivers of biotechnology businesses and apply their established skills for commercial success.
Biotechnology And Genetic Engineering
DOWNLOAD
Author : Kathy Wilson Peacock
language : en
Publisher: Infobase Publishing
Release Date : 2010
Biotechnology And Genetic Engineering written by Kathy Wilson Peacock and has been published by Infobase Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010 with Science categories.
Explains why biotechnology is a relevant and volatile issues. Begins with a history of biotechnology and its effect on agriculture, medicine, and the environment. Equal space is devoted to discussing the efforts of human-rights advocates, animal-rights advocates, and environmentalists to create definitive governmental regulations for this budding industry.
Building Biotechnology
DOWNLOAD
Author : Yali Friedman
language : en
Publisher: Thinkbiotech
Release Date : 2006
Building Biotechnology written by Yali Friedman and has been published by Thinkbiotech this book supported file pdf, txt, epub, kindle and other format this book has been release on 2006 with Business & Economics categories.
Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry: * Cultivate a career in biotechnology, with or without an MBA or Ph.D. * Fund and assemble a company * Manage research and development, alliances, and funding * Understand the diverse factors defining the biotechnology industry * Invest intelligently in biotechnology This second edition significantly expands upon the foundation laid by the first, updating recent developments and adding significantly more case studies, informative figures and tables.
Building Backwards To Biotech
DOWNLOAD
Author : Stephanie Wisner
language : en
Publisher:
Release Date : 2022-05-31
Building Backwards To Biotech written by Stephanie Wisner and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2022-05-31 with categories.
Ever wonder how medicines and vaccines enter the marketplace? Why they are so expensive? Most people have heard about Theranos, a story of failure: how do biotechnology start-ups actually succeed? In Building Backwards to Biotech, author Stephanie A. Wisner demystifies the subjects of biotechnology, start-ups, and finance to answer these questions. Wisner unlocks the secrets of how to build a biotech company successfully by keeping one process always in mind: Building Backwards. In this book you will understand the concept of Building Backwards and how it can: Increase your chances of starting a "winning" company Inform capital raising Lead to a strong clinical and scientific strategy Mitigate business and scientific risk from the outset Wisner believes in the power of entrepreneurship to drive cutting-edge science to market successfully and its ability to help people suffering with diseases currently considered untreatable. She believes good science combined with innovative business practices has the power to literally save and enrich lives. Building Backwards to Biotech will make it easier for interested individuals to bring this kind of work to a waiting world.
Building Global Biobrands
DOWNLOAD
Author : Françoise Simon
language : en
Publisher: Simon and Schuster
Release Date : 2003
Building Global Biobrands written by Françoise Simon and has been published by Simon and Schuster this book supported file pdf, txt, epub, kindle and other format this book has been release on 2003 with Business & Economics categories.
Two foremost marketing strategists combine their expertise in the first ever book to offer cutting-edge global strategies for marketing biotechnology. 20 charts & graphs.
Effective Technology Transfer In Biotechnology
DOWNLOAD
Author : Oliver Uecke
language : en
Publisher: World Scientific
Release Date : 2015-01-06
Effective Technology Transfer In Biotechnology written by Oliver Uecke and has been published by World Scientific this book supported file pdf, txt, epub, kindle and other format this book has been release on 2015-01-06 with Technology & Engineering categories.
Biotechnology is referred to as one of the key enabling technologies of the 21st century. It has the potential to offer solutions for a number of health and resource-based problems the world is facing, such as unmet medical needs and fossil fuel dependency. Considerable effort and investment has been expended in recent years to try and improve the outcomes of technology transfer in order to fulfill this potential. This book presents seventeen best-practice case studies on the topic of effective technology transfer in biotechnology. The selected case studies focus on technology transfer offices, funding models, incubators, education and clusters. Each presents an overview of an initiative that was deployed in Europe with the aim of supporting and stimulating the transfer of biotechnology discoveries and technologies from research laboratories to society. Readers are provided with a critical assessment of each initiative and policy makers, entrepreneurs, cluster managers and research institute managers will find inspiring lessons they can draw on when developing and implementing similar initiatives elsewhere. These cases are the product of research undertaken as part of the ETTBio (Effective Technology Transfer in Biotechnology) project, co-financed by the European Union (ERDF — European Regional Development Fund) and made possible by the INTERREG IVC Programme. ETTBio commenced in January 2012 and concluded in December 2014. Contents:Technology Transfer Office (TTO):Case Study 1: A Look Inside Imperial College's TTOCase Study 2: Technology Transfer at VIBCase Study 3: The Creation of a New Technology Transfer OfficeCase Study 4: A Model for IP Transfer and Shareholding for University Spin-Offs: The "Dresden Model"Funding:Case Study 5: Environmental Success Factors of Imperial College's TTOCase Study 6: The Industrial Research FundCase Study 7: Regional Innovation Vouchers as an Effective Tool for Supporting Technology TransferCase Study 8: Public Funds for Patenting, Valorization and Science-Industry CollaborationIncubators:Case Study 9: The Imperial BioincubatorCase Study 10: Idea Lab — A Platform for Students to Develop New IdeasEducation:Case Study 11: Entrepreneurship and Technology Transfer Education at the Vrije Universiteit BrusselCase Study 12: BioEmprenedor XXI: Guidance Program for Starting Up and Growing Companies in the Life Sciences ArenaCase Study 13: Education for ScientistsClusters:Case Study 14: The Biocat Model: Managing the Bioregion of CataloniaCase Study 15: The Effects of a Cluster on a Spin-Off — The Foundation of AblynxCase Study 16: Brokerage Event: Matching International R&D projectsCase Study 17: The DRESDEN-concept: A Focus on Shared Services and Facilities Readership: Policy makers, entrepreneurs, cluster managers and research institute managers in biotechnology. Key Features:Focuses on effective technology transfer in the European contextTechnology specific focus on biotechnologyIdentifies and provides a detailed examination of best practice case studies in technology transfer across Europe. These include both highly experienced regions such as London and Flanders as well as "newcomers" such as Poland and EstoniaKeywords:Technology Transfer;Biotechnology;Effectiveness;Efficiency;Commercialization;Research;Funding;Cluster;Education;Technology Transfer Offices;Incubation
Managing Biotechnology
DOWNLOAD
Author : Francoise Simon
language : en
Publisher: John Wiley & Sons
Release Date : 2017-09-01
Managing Biotechnology written by Francoise Simon and has been published by John Wiley & Sons this book supported file pdf, txt, epub, kindle and other format this book has been release on 2017-09-01 with Business & Economics categories.
A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”